Pancreatic Cancer
Conditions
Interventions
Pancreas cancer.
Benign oancreatic lesion.
Sponsors
Department of Endoscopy, The Jikei University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who had susppected pancreatic cancer, from the examinations of computed tomography or abdominal ultrasonography. 2. Performance status; 0,1,2 3. Over 20 years of age. 4. Patients who had informed consent
Exclusion criteria
Exclusion criteria: 1. Patients who receive anticoagulant drug or antiplatelet drug. 2. Patients affected with acute pancreatitis. 3. Patients undergone already chemotherapy or radiation therapy. 4. Women during pregnancy and of childbearing potential, or presently breastfeeding. 5. Patients who are affected with psychiatric disorder, and can not be enrolled in this clinical trial, due to loss of judgment. 6. Patients who are ruled unfit to enroll this crinical trial, in the judgment of endoscopists or attending doctors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i)VEGF-A and Flk-1 expression which obtained from EUS-FNA's specimen and those of surgical specimen, will be copared with each other. ii)To develop a new biomarker for pancreatic cancer diagnosis, the S100P expression is measured. | — |
Countries
Japan
Contacts
Public ContactHiroo Imazu
The Jikei University School of Medicine Department of Endoscopy
Outcome results
None listed